Phio Pharmaceuticals Corp

+0.01 (+0.45%)
Earnings Announcements

Phio Pharmaceuticals Reports Q3 Loss Per Share Of $0.40

Published: 11/10/2020 23:04 GMT
Phio Pharmaceuticals Corp (PHIO) - Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update.
Q3 Loss per Share $0.40.
Expects Cash Will Be Sufficient to Fund Currently Planned Operations for at Least Next 12 Months.
Ended Quarter With Total Cash of Approximately $16.9 Million As of September 30, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.